Jefferies Downgrades ISIS Pharmaceuticals (ISIS) Two-Notches to Underperform
Tweet Send to a Friend
Jefferies downgraded ISIS Pharmaceuticals (NASDAQ: ISIS) from Buy to Underperform with a price target of $10.00.
The firm comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE